期刊文献+

人肥大细胞类糜蛋白酶基因的原核表达及其多克隆抗体的制备与鉴定 被引量:4

Prokaryotic expression of human mast cell chymase gene and preparation of its polyclonal antibody
下载PDF
导出
摘要 目的:克隆人肥大细胞类糜蛋白酶cDNA,并进行原核表达,制备重组蛋白免疫家兔,制备兔抗类糜蛋白酶多克隆抗体。方法:用RT-PCR技术克隆类糜蛋白酶cDNA,用Gateway技术构建表达载体,以大肠杆菌为宿主,用L-阿拉伯糖诱导重组肥大细胞类糜蛋白酶的表达,经Ni-NTA-Agarose柱层析纯化后,以其为免疫原制备兔抗类糜蛋白酶多抗,并以间接ELISA测定抗体效价,以Westernblot鉴定抗体的特异性。结果:成功地克隆了人肥大细胞类糜蛋白酶cDNA,并在大肠杆菌BL21-AI中表达成功,用纯化的重组类糜蛋白酶为免疫原,免疫家兔制备了兔抗类糜蛋白酶抗体,ELISA结果显示效价达1:12800,Western blot分析表明该抗体能特异结合类糜蛋白酶。结论:以纯化的重组类糜蛋白酶为免疫原,成功地制备了效价及特异性较高的兔抗类糜蛋白酶抗体,为进一步建立简便的类糜蛋白酶检测方法及研究类糜蛋白酶生物学功能奠定了良好的基础。 AIM: To express the human mast cell chymase cDNA in E. coli and prepare the antibody against human mast cell chymase with recombinant chymase. METHODS: The human mast cell chymase cDNA was cloned by RT-PCR. The recombinant chymase was expressed in E. coli with L-Arabinose induction and purified by Ni-NTA agarose column. Then the purified chymase was used as immunogen to immunize the rabbit. The titer and specificity of the anti-chymase antibody from the rabbit were analyzed by indirect ELISA and Westem blot, respectively. RESULTS. The recombinant chymase was successfully expressed in E. coli, and the polyclonal anit-chymase antibody was prepared by immunizing the rabbit with the purified recombinant chymase. The titer of the generated antiserum was detected to be 1:12 800 by ELISA. Westem blot analysis showed this antibeday bound specifically with chymase. CONCLUSION: The anti-chymase antibody from the rabbit with high titer and specificity has been prepared with purified recombinant chymase as immunogen, which lays a foundation for further research into detection and function of chymase.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2007年第11期1025-1027,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 广东省自然科学基金资助项目(04300434) 广东医学院科研基金资助项目(XB0407)
关键词 人肥大细胞类糜蛋白酶 表达 抗体 制备 human mast cell chymase expression anti-body preparation
  • 相关文献

参考文献9

  • 1Ebihara N,Funaki T,Takai S,et al.Tear chymase in vernal keratoconjunctivitis[J].Curr Eye Res,2004,28(6):417-420.
  • 2Nishio H,Takai S,Miyazaki M,et al.Usefullness of serum mast cellspedific chymase levels for postmortem dignosis anaphylaxis[J].Int J Med,2005,119(2):331 -334.
  • 3Badertscher K,Bronnimann M,Karlen S,et al.Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis[J].Arch Dermatol Re,2005,296(10):503 -506.
  • 4Leskinen MJ,Heikkila HM,Speer MY,et al.Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-κB-mediated survival signaling[J].Exp Cell Res,2006,312(8):1289-1298.
  • 5谢华,何韶衡.特异性类胰蛋白酶抑制剂双苯甲脒对肥大细胞分泌的调控作用[J].细胞与分子免疫学杂志,2003,19(1):100-102. 被引量:20
  • 6陈章权,何素辉,陆田田,何天文,何韶衡.兔抗人肥大细胞羧肽酶抗体的制备与鉴定[J].细胞与分子免疫学杂志,2007,23(9):859-861. 被引量:10
  • 7Busso D,Delagoutte-Busso B,Moras D.Construction of a set Gateway-based destination vectors for high-throughput cloning and expression screening in Escherichia coli[J].Anal Biochem,2005,343 (2):313-321.
  • 8Bacani C,Frishman WH.Chymase:a new pharmacologic target in cardiovascular disease[J].Cardiol Rev,2006,14(4):187-193.
  • 9Takai S,Jin D,Muramatsu M,et al.Chymase as a novel target for the prevention of vascular diseases[J].Trends Pharmacol Sci,2004,25(10):518 -522.

二级参考文献18

  • 1[1]Church MK, Bradding P, Walls AF, et al. Human mast cells and basophils. In allergy and allergic diseases[M]. by AB Kay, Blackwell, Oxford. 1997:149-170.
  • 2[2]Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells[J]. Int Arch Allergy Appl Immunol, 1992, 97:216-222.
  • 3[3]Okayama Y, Benyon RC, Lowman MA, et al. In vitro effects of H1-antihistamine and PGD2 release from mast cells of human lung, tonsil and skin[J]. Allergy, 1994, 49:246-253.
  • 4[4]Butchers PR, Vardey CJ, Johnson M. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung[J]. Br J Pharmacol, 1991, 104:672-676.
  • 5[5]Naclerio R, Kagey-Sobotka MA, Lichtenstein LM, et al. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human[J]. Am Rev Respir Dis, 1990, 142:167-171.
  • 6[6]He S, Gaca MDA, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase[J]. J Pharmacol Exp Ther, 1998, 286:289-297.
  • 7[7]Clark JM, Abraham WM, Fishman CE, et al. Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep[J]. Am J Respir Crit Care Med, 1995, 152:2076-2083.
  • 8[8]Burgess LE, Newhouse BJ, Ibrahim P, et al. Potent selective nonpeptidic inhibitors of human lung tryptase[J]. Proc Natl Acad Sci USA, 1999, 96:8348-8352.
  • 9[9]Buckley MG, Variend S, Walls AF. Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in sudden infant death syndrome (SIDS). An investigation of anaphylactic mechanisms[J]. Clin Exp Allergy, 2001, 11:1696-1704.
  • 10[10]Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from dispersed lung mast cells by anti-allergic drugs and salbutamol[J]. Br J Pharmacol, 1987, 90:421-429.

共引文献28

同被引文献35

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部